Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-21

Clinical Trial Update: Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating Campath-1H induction to enable steroid-free immunosuppression in pediatric renal transplantation; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Campath-1H (alemtuzumab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Disorder Related to Renal Transplantation | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-09-21